Home › Companies › NUVATION BIO INC. › 2024-2025
Compiled from SEC Form N-PX filings and NUVATION BIO INC.’s Form 8-K, filed 2024-09-05 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Proxy season: 2024-2025 2025-2026
Explore NUVATION BIO INC. in the interactive database Compare manager voting policies
These tallies are NUVATION BIO INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-09-05 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX. NUVATION BIO INC. reported 2 meetings in this season; each is tabulated separately below, with its own filing.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Min Cui, Ph.D. | 210,137,812 | -- | -- | 742,967 | 20,585,212 | Majority: yes |
| Proposal 2: Ratification of Independent Registered Public Accounting Firm. The Company's stockholders ratified the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. | 231,131,143 | 217,489 | 117,359 | -- | 0 | Majority: yes |
| Proposal 3: To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement. The Company's stockholders approved, on an advisory basis, the compensation of the Company's named executive officers | 208,479,505 | 1,832,719 | 568,555 | -- | 20,585,212 | Majority: yes |
| Proposal 4: To approve conversion of the outstanding shares of Series A Non-Voting Convertible Preferred Stock to Class A Common Stock. The Company's stockholders approved for the purpose of complying with the listing rules of the New York Stock Exchange (NYSE | 179,742,172 | 2,919,589 | 572,763 | -- | 20,585,212 | Majority: yes |
Source: NUVATION BIO INC., Form 8-K, filed with the SEC on 2024-09-05 — read the filing on EDGAR.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Kathryn E. Falberg | 198,624,124 | -- | -- | 18,024,599 | 64,812,107 | Majority: yes |
| Proposal 2: Ratification of Independent Registered Public Accounting Firm. The Company's stockholders ratified the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. | 279,883,301 | 1,561,729 | 15,800 | -- | 0 | Majority: yes |
| Proposal 3: To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement. The Company's stockholders approved, on an advisory basis, the compensation of the Company's named executive officers | 214,903,033 | 1,601,869 | 143,821 | -- | 64,812,107 | Majority: yes |
Source: NUVATION BIO INC., Form 8-K, filed with the SEC on 2025-05-23 — read the filing on EDGAR.
Each item below shows how the 168 asset managers that disclosed a NUVATION BIO INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of NUVATION BIO INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Meeting held 2024-09-03.
Combines 6 wordings of this item as funds reported it.
99.1% Majority: yes · of votes cast
NUVATION BIO INC.’s own tally for this item (“Proposal 3: To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement. The Company's stockholders approved, on an advisory basis, the compensation of”): 208,479,505 for, 1,832,719 against, per its Form 8-K filed 2024-09-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 248,624,729 outstanding shares: 84% for, 0.8% against (85% of the company cast a for/against vote).
The 130 asset managers below cast 99.1% of the shares they voted on this item FOR (124,460,236 for, 1,051,876 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 50,026,673 | 0 | 0 | 0 | For |
| EcoR1 Capital, LLC | 13,844,016 | 0 | 0 | 0 | For |
| BlackRock | 13,026,475 | 17,733 | 0 | 0 | For |
| Vanguard | 10,348,626 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 3,968,417 | 0 | 0 | 0 | For |
| ABRAMS CAPITAL MANAGEMENT, L.P. | 3,811,513 | 0 | 0 | 0 | For |
| State Street | 2,985,366 | 1,372 | 0 | 0 | For |
| Octagon Capital Advisors LP | 2,984,013 | 0 | 0 | 0 | For |
| Charles Schwab | 2,694,703 | 0 | 0 | 0 | For |
| Aisling Capital Management LP | 2,541,009 | 0 | 0 | 0 | For |
| Citadel | 1,927,360 | 0 | 0 | 0 | For |
| Nuveen | 1,901,472 | 0 | 0 | 0 | For |
| TIAA | 1,643,608 | 0 | 0 | 0 | For |
| Northern Trust | 1,349,969 | 0 | 0 | 0 | For |
| Dimensional | 935,618 | 0 | 0 | 0 | For |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 892,162 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 752,871 | 0 | 0 | 0 | For |
| Federated Hermes | 724,027 | 0 | 0 | 0 | For |
| Two Sigma | 569,184 | 0 | 0 | 0 | For |
| American Century | 0 | 538,594 | 0 | 0 | Against |
| Wellington | 515,002 | 0 | 0 | 0 | For |
| Clearline Capital LP | 437,237 | 0 | 0 | 0 | For |
| T. Rowe Price | 419,755 | 0 | 0 | 0 | For |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 387,342 | 0 | 0 | 0 | For |
| SEI | 385,978 | 0 | 0 | 0 | For |
Showing the 25 largest of 130 asset managers. See all 130 in the interactive database.
Meeting held 2025-05-21.
Combines 9 wordings of this item as funds reported it.
99.2% Majority: yes · of votes cast
NUVATION BIO INC.’s own tally for this item (“Proposal 3: To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement. The Company's stockholders approved, on an advisory basis, the compensation of”): 214,903,033 for, 1,601,869 against, per its Form 8-K filed 2025-05-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.
The 120 asset managers below cast 99% of the shares they voted on this item FOR (152,669,750 for, 1,848,079 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 78,900,675 | 0 | 0 | 0 | For |
| Decheng Capital LLC | 0 | 0 | 0 | 0 | Unknown |
| Vanguard | 15,502,825 | 0 | 0 | 0 | For |
| Omega Fund Management, LLC | 13,072,340 | 0 | 0 | 0 | For |
| BlackRock | 9,649,890 | 19,773 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 5,089,524 | 0 | 0 | 0 | For |
| Charles Schwab | 3,798,158 | 0 | 0 | 0 | For |
| MPM BioImpact LLC | 3,499,122 | 0 | 0 | 0 | For |
| Laurion Capital Management LP | 3,134,606 | 0 | 0 | 0 | For |
| Redmile Group, LLC | 3,031,009 | 0 | 0 | 0 | For |
| Octagon Capital Advisors LP | 2,633,504 | 0 | 0 | 0 | For |
| State Street | 1,992,164 | 1,131 | 0 | 0 | For |
| Citadel | 1,535,121 | 0 | 0 | 0 | For |
| Northern Trust | 1,253,189 | 0 | 0 | 0 | For |
| Dimensional | 1,222,009 | 0 | 0 | 0 | For |
| American Century | 0 | 929,861 | 0 | 0 | Against |
| UBS | 571,621 | 286,664 | 0 | 0 | For |
| Palo Alto Investors LP | 772,652 | 0 | 0 | 0 | For |
| Two Sigma | 642,302 | 0 | 0 | 0 | For |
| Exome Asset Management LLC | 555,376 | 0 | 0 | 0 | For |
| Equitable | 514,962 | 0 | 0 | 0 | For |
| Wellington | 502,872 | 0 | 0 | 0 | For |
| SEI | 421,516 | 0 | 0 | 0 | For |
| Nuveen | 412,492 | 0 | 0 | 0 | For |
| TIAA | 407,068 | 0 | 0 | 0 | For |
Showing the 25 largest of 120 asset managers. See all 120 in the interactive database.
Meeting held 2024-09-03.
Combines 4 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
NUVATION BIO INC.’s own tally for this item (“Proposal 4: To approve conversion of the outstanding shares of Series A Non-Voting Convertible Preferred Stock to Class A Common Stock. The Company's stockholders approved for the purpose of complying with the listing ru”): 179,742,172 for, 2,919,589 against, per its Form 8-K filed 2024-09-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 248,624,729 outstanding shares: 72% for, 1% against (73% of the company cast a for/against vote).
The 48 asset managers below cast 99.0% of the shares they voted on this item FOR (47,155,711 for, 459,547 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 21,071,540 | 0 | 0 | 0 | For |
| Vanguard | 9,999,264 | 0 | 0 | 0 | For |
| BlackRock | 8,255,183 | 0 | 0 | 0 | For |
| TIAA | 1,896,048 | 0 | 0 | 0 | For |
| Charles Schwab | 1,347,201 | 0 | 0 | 0 | For |
| Dimensional | 830,105 | 0 | 0 | 0 | For |
| Equitable | 420,669 | 0 | 0 | 0 | For |
| Federated Hermes | 361,146 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 357,839 | 0 | 0 | 0 | For |
| State Street | 689 | 305,166 | 0 | 0 | Against |
| American Century | 269,297 | 0 | 0 | 0 | For |
| Nationwide | 269,106 | 0 | 0 | 0 | For |
| SEI | 246,583 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 234,030 | 0 | 0 | 0 | For |
| Lincoln Financial | 77,918 | 142,500 | 0 | 0 | Against |
| Northern Trust | 137,534 | 0 | 0 | 0 | For |
| Thrivent | 107,961 | 0 | 0 | 0 | For |
| Global X | 98,817 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 96,552 | 0 | 0 | 0 | For |
| ETF Series Solutions | 89,606 | 0 | 0 | 0 | For |
| Invesco | 82,454 | 0 | 0 | 0 | For |
| Pacific Life | 81,819 | 0 | 0 | 0 | For |
| T. Rowe Price | 81,560 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 81,302 | 0 | 0 | 0 | For |
| John Hancock | 78,125 | 0 | 0 | 0 | For |
Showing the 25 largest of 48 asset managers. See all 48 in the interactive database.
Meeting held 2024-09-03.
Combines 4 wordings of this item as funds reported it.
99.6% Majority: yes · of votes cast
NUVATION BIO INC.’s own tally for this item (“Elect Director: Min Cui, Ph.D.”): 210,137,812 for, 742,967 withheld, per its Form 8-K filed 2024-09-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 248,624,729 outstanding shares: 85% for, 0.3% withheld (85% of the company cast a for/withheld vote).
The 48 asset managers below cast 100% of the shares they voted on this item FOR (47,615,258 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 21,071,540 | 0 | 0 | 0 | For |
| Vanguard | 9,999,264 | 0 | 0 | 0 | For |
| BlackRock | 8,255,183 | 0 | 0 | 0 | For |
| TIAA | 1,896,048 | 0 | 0 | 0 | For |
| Charles Schwab | 1,347,201 | 0 | 0 | 0 | For |
| Dimensional | 830,105 | 0 | 0 | 0 | For |
| Equitable | 420,669 | 0 | 0 | 0 | For |
| Federated Hermes | 361,146 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 357,839 | 0 | 0 | 0 | For |
| State Street | 305,855 | 0 | 0 | 0 | For |
| American Century | 269,297 | 0 | 0 | 0 | For |
| Nationwide | 269,106 | 0 | 0 | 0 | For |
| SEI | 246,583 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 234,030 | 0 | 0 | 0 | For |
| Lincoln Financial | 220,418 | 0 | 0 | 0 | For |
| Northern Trust | 137,534 | 0 | 0 | 0 | For |
| Thrivent | 107,961 | 0 | 0 | 0 | For |
| Global X | 98,817 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 96,552 | 0 | 0 | 0 | For |
| ETF Series Solutions | 89,606 | 0 | 0 | 0 | For |
| Invesco | 82,454 | 0 | 0 | 0 | For |
| Pacific Life | 81,819 | 0 | 0 | 0 | For |
| T. Rowe Price | 81,560 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 81,302 | 0 | 0 | 0 | For |
| John Hancock | 78,125 | 0 | 0 | 0 | For |
Showing the 25 largest of 48 asset managers. See all 48 in the interactive database.
Meeting held 2024-09-03.
98% fund support · no official result
The 47 asset managers below cast 98% of the shares they voted on this item FOR (46,548,095 for, 998,934 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 21,071,540 | 0 | 0 | 0 | For |
| Vanguard | 9,999,264 | 0 | 0 | 0 | For |
| BlackRock | 8,255,183 | 0 | 0 | 0 | For |
| TIAA | 1,896,048 | 0 | 0 | 0 | For |
| Charles Schwab | 1,347,201 | 0 | 0 | 0 | For |
| Dimensional | 830,105 | 0 | 0 | 0 | For |
| Equitable | 420,669 | 0 | 0 | 0 | For |
| Federated Hermes | 361,146 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 357,839 | 0 | 0 | 0 | For |
| State Street | 689 | 305,166 | 0 | 0 | Against |
| American Century | 269,297 | 0 | 0 | 0 | For |
| Nationwide | 259,374 | 9,732 | 0 | 0 | For |
| SEI | 0 | 246,583 | 0 | 0 | Against |
| Columbia Threadneedle | 234,030 | 0 | 0 | 0 | For |
| Lincoln Financial | 77,918 | 142,500 | 0 | 0 | Against |
| Northern Trust | 137,534 | 0 | 0 | 0 | For |
| Thrivent | 107,961 | 0 | 0 | 0 | For |
| Global X | 0 | 98,817 | 0 | 0 | Against |
| AIG/SunAmerica | 96,552 | 0 | 0 | 0 | For |
| ETF Series Solutions | 89,606 | 0 | 0 | 0 | For |
| Invesco | 82,454 | 0 | 0 | 0 | For |
| Pacific Life | 81,819 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 81,560 | 0 | 0 | Against |
| Bridge Builder Trust | 81,302 | 0 | 0 | 0 | For |
| John Hancock | 78,125 | 0 | 0 | 0 | For |
Showing the 25 largest of 47 asset managers. See all 47 in the interactive database.
Meeting held 2024-09-03.
Combines 2 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
NUVATION BIO INC.’s own tally for this item (“Proposal 2: Ratification of Independent Registered Public Accounting Firm. The Company's stockholders ratified the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal yea”): 231,131,143 for, 217,489 against, per its Form 8-K filed 2024-09-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 248,624,729 outstanding shares: 93% for, 0.1% against (93% of the company cast a for/against vote).
The 46 asset managers below cast 100% of the shares they voted on this item FOR (47,017,351 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 21,071,540 | 0 | 0 | 0 | For |
| Vanguard | 9,999,264 | 0 | 0 | 0 | For |
| BlackRock | 8,255,183 | 0 | 0 | 0 | For |
| TIAA | 1,643,608 | 0 | 0 | 0 | For |
| Charles Schwab | 1,347,201 | 0 | 0 | 0 | For |
| Dimensional | 830,105 | 0 | 0 | 0 | For |
| Federated Hermes | 361,146 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 357,839 | 0 | 0 | 0 | For |
| State Street | 305,855 | 0 | 0 | 0 | For |
| American Century | 269,297 | 0 | 0 | 0 | For |
| Nationwide | 252,495 | 0 | 0 | 0 | For |
| Equitable | 235,530 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 234,030 | 0 | 0 | 0 | For |
| Lincoln Financial | 220,418 | 0 | 0 | 0 | For |
| SEI | 139,240 | 0 | 0 | 0 | For |
| Northern Trust | 137,534 | 0 | 0 | 0 | For |
| Thrivent | 107,961 | 0 | 0 | 0 | For |
| Global X | 98,817 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 96,552 | 0 | 0 | 0 | For |
| ETF Series Solutions | 89,606 | 0 | 0 | 0 | For |
| Invesco | 82,454 | 0 | 0 | 0 | For |
| Pacific Life | 81,819 | 0 | 0 | 0 | For |
| T. Rowe Price | 81,560 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 81,302 | 0 | 0 | 0 | For |
| John Hancock | 78,125 | 0 | 0 | 0 | For |
Showing the 25 largest of 46 asset managers. See all 46 in the interactive database.
Meeting held 2025-05-21.
Combines 3 wordings of this item as funds reported it.
92% Majority: yes · of votes cast
NUVATION BIO INC.’s own tally for this item (“Elect Director: Kathryn E. Falberg”): 198,624,124 for, 18,024,599 withheld, per its Form 8-K filed 2025-05-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.
The 41 asset managers below cast 100% of the shares they voted on this item FOR (49,940,769 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 27,142,962 | 0 | 4,489,865 | 0 | For |
| Vanguard | 14,991,135 | 0 | 0 | 0 | For |
| BlackRock | 4,573,037 | 0 | 411,202 | 0 | For |
| Charles Schwab | 1,898,919 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 1,030,309 | 0 | Abstain |
| Equitable | 317,573 | 0 | 197,389 | 0 | For |
| American Century | 0 | 0 | 481,171 | 0 | Abstain |
| TIAA | 0 | 0 | 407,068 | 0 | Abstain |
| Northern Trust | 301,765 | 0 | 0 | 0 | For |
| SEI | 210,185 | 0 | 0 | 0 | For |
| Invesco | 172,341 | 0 | 0 | 0 | For |
| Lincoln Financial | 0 | 0 | 134,500 | 0 | Abstain |
| Global X | 108,429 | 0 | 0 | 0 | For |
| Pacific Life | 91,871 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 81,302 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 80,215 | 0 | Abstain |
| ETFis Series Trust I | 0 | 0 | 62,421 | 0 | Abstain |
| ETF Series Solutions | 0 | 0 | 51,266 | 0 | Abstain |
| Brighthouse | 0 | 0 | 50,799 | 0 | Abstain |
| John Hancock | 0 | 0 | 42,525 | 0 | Abstain |
| State Street | 33 | 0 | 36,937 | 0 | Abstain |
| Direxion Shares ETF Trust | 0 | 0 | 33,576 | 0 | Abstain |
| Nationwide | 31,679 | 0 | 0 | 0 | For |
| Jackson National | 0 | 0 | 29,713 | 0 | Abstain |
| DWS | 0 | 0 | 28,322 | 0 | Abstain |
Showing the 25 largest of 41 asset managers. See all 41 in the interactive database.
Meeting held 2025-05-21.
99.4% Majority: yes · of votes cast
NUVATION BIO INC.’s own tally for this item (“Proposal 2: Ratification of Independent Registered Public Accounting Firm. The Company's stockholders ratified the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal yea”): 279,883,301 for, 1,561,729 against, per its Form 8-K filed 2025-05-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.
The 38 asset managers below cast 100% of the shares they voted on this item FOR (57,187,368 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 31,632,827 | 0 | 0 | 0 | For |
| Vanguard | 14,976,973 | 0 | 0 | 0 | For |
| BlackRock | 4,633,168 | 0 | 0 | 0 | For |
| Charles Schwab | 1,898,919 | 0 | 0 | 0 | For |
| Dimensional | 1,030,309 | 0 | 0 | 0 | For |
| Equitable | 514,962 | 0 | 0 | 0 | For |
| American Century | 448,690 | 0 | 0 | 0 | For |
| TIAA | 407,068 | 0 | 0 | 0 | For |
| Northern Trust | 301,765 | 0 | 0 | 0 | For |
| SEI | 210,185 | 0 | 0 | 0 | For |
| Invesco | 172,341 | 0 | 0 | 0 | For |
| Lincoln Financial | 134,500 | 0 | 0 | 0 | For |
| Global X | 108,429 | 0 | 0 | 0 | For |
| Pacific Life | 91,871 | 0 | 0 | 0 | For |
| ProShares | 80,215 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 62,421 | 0 | 0 | 0 | For |
| ETF Series Solutions | 51,266 | 0 | 0 | 0 | For |
| Brighthouse | 41,862 | 0 | 8,937 | 0 | For |
| John Hancock | 42,525 | 0 | 0 | 0 | For |
| State Street | 36,970 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 33,576 | 0 | 0 | 0 | For |
| Nationwide | 31,679 | 0 | 0 | 0 | For |
| Jackson National | 29,713 | 0 | 0 | 0 | For |
| DWS | 28,322 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 27,709 | 0 | 0 | 0 | For |
Showing the 25 largest of 38 asset managers. See all 38 in the interactive database.
Ranked by the number of NUVATION BIO INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 248,624,729 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 20.12% |
| 2 | EcoR1 Capital, LLC | 5.57% |
| 3 | BlackRock | 5.25% |
| 4 | Vanguard | 4.16% |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 1.60% |
| 6 | ABRAMS CAPITAL MANAGEMENT, L.P. | 1.53% |
| 7 | State Street | 1.20% |
| 8 | Octagon Capital Advisors LP | 1.20% |
| 9 | Charles Schwab | 1.08% |
| 10 | Aisling Capital Management LP | 1.02% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| David Hung, M.D. | 23.84% | DEF14A |
| FMR (Fidelity) | 20.35% | 13F |
| Entities affiliated with FMR LLC | 18.21% | DEF14A |
| Entities affiliated with Decheng Anbio Limited | 10.44% | DEF14A |
| Min Cui, Ph.D. | 10.44% | DEF14A |
| BlackRock | 7.43% | 13F |
| Vanguard Group | 6.19% | 13F |
| Geode Capital | 2.06% | 13F |
| State Street | 1.95% | 13F |
| Millennium Management | 1.52% | 13F |
Percentages above are of 248,624,729 shares outstanding, as reported by NUVATION BIO INC. on its Form 10-Q dated 2024-06-30 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from NUVATION BIO INC.’s 10-Q dated 2024-06-30. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At NUVATION BIO INC.'s 2 shareholder meetings in the 2024-2025 proxy season (held 2024-09-03 and 2025-05-21), 168 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,473 separate fund positions. Their filings are grouped here into 8 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item of the season, voted at the meeting held 2024-09-03 — TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS AS… — FOR was 99.1% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: NUVATION BIO INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-09-05.
NUVATION BIO INC. proxy season coverage: 2024-2025 (this page) · 2025-2026.